This week in Other Barks & Bites: the Office of the United States Trade Representative says it supports delaying a decision to extend the waiver of IP rights under the TRIPS Agreement to diagnostics and therapeutics and orders an investigation be conducted on the matter by the U.S. International Trade Commission; Ericsson and Apple Settle all patent litigation; the U.S. Patent and Trademark Office (USPTO) announces the February launch of an accelerated program for patents related to cancer research technology; Pfizer countersues Moderna in an ongoing patent case related to COVID-19 vaccines; Cisco avoids paying $2 billion in fines in a patent infringement case; and Huawei signs a deal with a tech competitor in a landmark licensing agreement.

Full Article Available Here